Media & Resources

Filter by

Type
- All types
- Fact Sheets & Publications
- Features
- IAVI Report
- In The News
- Podcasts
- Press Releases
- Scientific Publications
- Vaccine Literacy Library
- Videos
Health area
- Clinical trials(2)
- COVID-19(60)
- Ebola Sudan(40)
- EID(2)
- Emerging infectious diseases(1)
- Global access(13)
- HIV(409)
- Lassa fever(41)
- Lassa virus(1)
- Malaria(1)
- Marburg(18)
- Marburg virus(1)
- Other(103)
- Sexually transmitted infections(1)
- Snakebite(6)
- Sudan virus(9)
- TB(1)
- Tuberculosis(82)
- Vaccine research(19)
Location
- Africa(251)
- Europe(34)
- Global(475)
- India(17)
- Japan(1)
- United States(27)
- US(4)
- USA(3)
- Washington(1)
Topic
- Access(19)
- Antibodies(92)
- Capacity strengthening(13)
- Clinical trials(117)
- Community engagement(43)
- Emerging infectious diseases(1)
- Epidemiology(43)
- Funding(46)
- Germline targeting(5)
- Global access(8)
- Key populations(8)
- Pandemic preparedness(31)
- Partnerships(41)
- People(61)
- Policy and advocacy(47)
- Regulatory pathways(6)
- Social-behavioral research(3)
- Vaccine research(255)
Year
Journal
- Acta Crystallogr. D Biol. Crystallogr.(1)
- Addict Behav Rep(1)
- Afr J Lab Med(1)
- AIDS(41)
- AIDS Behav(10)
- AIDS Behav.(1)
- AIDS Care(5)
- AIDS Patient Care STDS(1)
- AIDS Res Hum Retroviruses(25)
- AIDS Res Ther(1)
- Am J Mens Health(1)
- Am J Public Health(1)
- Anal. Biochem.(1)
- Angew. Chem. Int. Ed. Engl.(2)
- Ann. Hum. Genet.(1)
- Ann. Intern. Med.(1)
- Ann. N. Y. Acad. Sci.(1)
- Ann. Oncol.(1)
- Annu. Rev. Immunol.(1)
- Annu. Rev. Med.(1)
- Biochemistry(3)
- Biologicals(3)
- Biomolecules(1)
- Biores Open Access(1)
- bioRxiv(1)
- Biotechnol Bioeng(2)
- Biotechnol J(1)
- Blood(1)
- BMC Biochem.(1)
- BMC Global Public Health(1)
- BMC Health Serv Res(2)
- BMC Immunol.(1)
- BMC Infect Dis(6)
- BMC Infect Dis.(1)
- BMC Med(2)
- BMC Med Educ(1)
- BMC Med Res Methodol(1)
- BMC Public Health(7)
- BMC Res Notes(1)
- BMC Womens Health(2)
- BMJ Glob Health(1)
- BMJ Open(2)
- Br. Med. Bull.(1)
- Bull. World Health Organ.(1)
- Campbell Syst Rev(1)
- Cell(10)
- Cell Chem Biol(1)
- Cell Host Microbe(2)
- Cell Rep(15)
- Chem Asian J(1)
- Chem. Biol.(1)
- Chem. Commun. (Camb.)(1)
- Clin Infect Dis(4)
- Clin. Vaccine Immunol.(3)
- Cogent Med(1)
- Contemp Clin Trials Commun(1)
- Contraception(3)
- Cult Health Sex(1)
- Curr Opin HIV AIDS(5)
- Curr. HIV Res.(1)
- Curr. Opin. Biotechnol.(1)
- Curr. Opin. Immunol.(3)
- Curr. Opin. Mol. Ther.(1)
- Curr. Opin. Struct. Biol.(1)
- Curr. Pharm. Des.(1)
- Curr. Top. Microbiol. Immunol.(1)
- Current Opinion in HIV and AIDS(1)
- East Afr Med J(2)
- eBioMedicine(3)
- Elife(1)
- Epidemiol. Infect.(1)
- Epidemiology(1)
- Eur. J. Immunol.(2)
- Expert Rev Vaccines(7)
- FASEB J.(1)
- Front Cell Infect Microbiol(1)
- Front Immunol(14)
- Front Microbiol(2)
- Front Public Health(1)
- Front Reprod Health(2)
- Gates Open Res(1)
- Gene Ther.(1)
- Genes Immun.(3)
- Global Health(1)
- Glycobiology(3)
- Health Aff (Millwood)(2)
- Health Policy(1)
- Health Promot Int(1)
- Health Res Policy Syst(1)
- HIV Med(1)
- Hum Vaccin(2)
- Hum Vaccin Immunother(2)
- Hum. Genet.(1)
- Human Vaccines & Immunotherapeutics(1)
- IJID Reg(1)
- Immunity(30)
- Immunol. Rev.(4)
- Indian J Pediatr(2)
- Indian J. Med. Res.(4)
- Int Health(3)
- Int J Epidemiol(2)
- Int J Med Inform(2)
- Int J STD AIDS(4)
- J Adv Manuf Process(1)
- J Antimicrob Chemother(1)
- J Comput Chem(1)
- J Exp Med(1)
- J Family Med Prim Care(1)
- J HIV AIDS Surveill Epidemiol(1)
- J Immunol(16)
- J Infect Dis(16)
- J Int AIDS Soc(14)
- J Pharm Sci(2)
- J Womens Health (Larchmt)(1)
- J. Acquir. Immune Defic. Syndr.(16)
- J. Am. Chem. Soc.(3)
- J. Am. Soc. Mass Spectrom.(1)
- J. Biol. Chem.(9)
- J. Clin. Invest.(2)
- J. Clin. Microbiol.(1)
- J. Exp. Med.(11)
- J. Gen. Virol.(11)
- J. Hepatol.(1)
- J. Immunol. Methods(9)
- J. Med. Primatol.(1)
- J. Mol. Biol.(6)
- J. Pept. Sci.(1)
- J. Virol.(115)
- J. Virol. Methods(2)
- JCI Insight(1)
- JMIR Res Protoc(1)
- Lancet(12)
- Lancet Glob Health(1)
- Lancet HIV(3)
- Lancet Infect Dis(3)
- lancet microbe(2)
- Lancet Respir Med(1)
- mBio(4)
- medRxiv(1)
- Methods Mol. Med.(1)
- Microbiol Spectr(2)
- Microorganisms(1)
- Mol Ther Methods Clin Dev(1)
- Mol. Ther.(3)
- Mucosal Immunol(1)
- N. Engl. J. Med.(7)
- Nat Commun(18)
- Nat Immunol(2)
- Nat Med(15)
- Nat Microbiol(2)
- Nat. Biotechnol.(1)
- Nat. Chem. Biol.(1)
- Nat. Immunol.(5)
- Nat. Rev. Immunol.(1)
- Nat. Rev. Microbiol.(1)
- Nat. Struct. Mol. Biol.(4)
- Nature(20)
- NEJM(1)
- npj Vaccines(3)
- Nucleic Acids Res.(1)
- Open Forum Infect Dis(2)
- Org. Biomol. Chem.(1)
- Orphanet J Rare Dis.(1)
- Pan Afr Med J(3)
- PDA J Pharm Sci Technol(1)
- Pharmaceut Med(1)
- Pharmacoeconomics(2)
- PLoS Glob Public Health(7)
- PLoS Med.(5)
- PLoS Negl Trop Dis(1)
- PLoS One(86)
- PLoS Pathog(36)
- Proc Natl Acad Sci U S A(32)
- Proteins(1)
- Proteomics(2)
- Rapid Commun. Mass Spectrom.(1)
- Res Involv Engagem(1)
- Retrovirology(13)
- Rev. Med. Virol.(1)
- S. Afr. Med. J.(1)
- Sci Adv(2)
- Sci Immunol(5)
- Sci Rep(8)
- Sci Transl Med(11)
- Science(38)
- Sex Health(1)
- Sex Transm Dis(4)
- Sex Transm Infect(12)
- Southeast Asian J. Trop. Med. Public Health(1)
- Springerplus(1)
- Structure(4)
- Stud Fam Plann(1)
- Syst Rev(1)
- Ther Adv Vaccines(1)
- Top HIV Med(1)
- Toxins(1)
- Trends Microbiol.(1)
- Trends Parasitol(1)
- Trop Dis Travel Med Vaccines(1)
- Trop. Med. Int. Health(7)
- Vaccine(33)
- Vaccines (Basel)(3)
- Virology(36)
- Viruses(1)
- Wellcome Open Res(1)
- Women's Health (Lond)(1)
Publication
- AARP(1)
- ABC 10 News in San Diego,(1)
- ABC News(1)
- ABCNEWS(1)
- AFP News(1)
- AIDSmap(1)
- ANI(1)
- Apna Radio 96.9 fm(1)
- AVAC(1)
- BBC(1)
- BioSpace,(1)
- BioWorld,(1)
- Bloomberg(4)
- Bloomberg Businessweek(1)
- BNN Bloomberg(1)
- Business Daily(1)
- Business Insider(2)
- Center for Global Development(1)
- CEPI(2)
- CGTN(1)
- Chemical & Engineering News(1)
- CIDRAP(4)
- Clinical Trials Arena(2)
- CNBC(1)
- CNN(4)
- CNN International(1)
- Contagion Live(1)
- Cope,(1)
- CSIS(1)
- CSIS Global Health Policy Center(1)
- Daily Mail(1)
- Daily Maverick(1)
- Daily Nation(2)
- Devex(7)
- Drug Discovery & Development,(1)
- Ebru TV (video)(1)
- Economic Times(1)
- El Confidencial(1)
- El Español,(1)
- El Global,(1)
- El País(2)
- EndPoints News(1)
- Es Radio Albacete,(1)
- ETHealthWorld (video)(1)
- EU Observer(1)
- European Commission(1)
- Fierce Pharma,(1)
- Financial Times(1)
- Fox News,(1)
- Gates Foundation(1)
- Gavi(7)
- GEN,(1)
- GeneOnline(1)
- Genetic Engineering & Biotechnology News(1)
- Global Health NOW(1)
- Global Health Technologies Coalition(1)
- HCP Live,(1)
- Health Affairs,(1)
- Health Analytics Asia(1)
- Health Policy Watch(2)
- Hutch News Service(1)
- Indian Express(2)
- Inside Precision Medicine(1)
- International Business Times,(1)
- International Development Research Centre(1)
- La Razón(1)
- La Razón,(1)
- La Tribuna de Albacete(1)
- La Voz de Galicia(1)
- Le Monde(1)
- Los Angeles Times(2)
- Managed Healthcare Executive(2)
- Medical New Today(1)
- MedPage Today(1)
- Memorias(1)
- mosaic(1)
- Nasdaq,(1)
- National Geographic(1)
- National Review(1)
- Nature(6)
- Nature Biotechnology(1)
- Nature India(1)
- NBC News(1)
- New Scientist(1)
- News 18 India(1)
- Newsweek(1)
- NIAID(1)
- Nigeria Health Watch(3)
- Nigerian Television Authority(1)
- NPR(1)
- NPR Goats & Soda(1)
- NPR Goats and Soda(1)
- Person Place Thing (podcast)(1)
- PharmaVoice(1)
- Pindula(1)
- Politico(1)
- Popular Science(1)
- Positively Aware(1)
- Posterity Media(1)
- POZ(2)
- Precision Vaccinations,(1)
- ProPatiens(1)
- ProPatients(2)
- Pulse Nigeria(1)
- Refinery 29(1)
- Results UK(1)
- Reuters(2)
- Reuters,(1)
- Rolling Stone(1)
- Salon(2)
- Sayansi Magazine(1)
- SciDevNet,(2)
- Science(9)
- ScienceNews(1)
- Scroll.in(1)
- Spotlight(1)
- Standard(1)
- STAT(7)
- STAT News(13)
- STAT Plus (Subscription Required)(2)
- TechCrunch,(1)
- Telecinco,(2)
- The Advocate(1)
- The Associated Press(1)
- The BMJ(1)
- The Conversation(1)
- The Daily Nation(2)
- The Guardian(2)
- The Guardian Nigeria(2)
- The HILL(3)
- The Indian Express(1)
- THE LANCET(4)
- The New Times(1)
- The New York Times(3)
- The Observer(1)
- The Philadelphia Inquirer(1)
- The Standard(1)
- The Star(1)
- The Telegraph(4)
- The Voice of America(1)
- The Wall Street Journal(1)
- The Washington Post(2)
- The Wire(2)
- them.(1)
- TIDES Global(1)
- Times of India(2)
- USAID Blog(1)
- Vaccine Insights(1)
- VaccinesToday(1)
- VICE(1)
- Wall Street Journal,(1)
- WebMD(1)
- Weill Cornell(1)
- WIRED(1)
- World Health Organization(2)
- World Pharmaceutical Frontiers(1)
- Yale School of Medicine(1)
- Zendal(1)
Fact sheet & publication type
- Annual Reports(7)
- Community Engagement Resources(15)
- Fact Sheets(12)
- Policy and Advocacy Publications(23)
Keyword search
Clear all

In The News

Lassa vaccine candidate provides encouraging results in phase 1 trial

CIDRAP

November 7, 2025

Press Releases

Encouraging results from a first-in-human Phase 1 clinical trial of IAVI’s Lassa vaccine candidate published in New England Journal of Medicine

November 6, 2025

One dose elicits robust and long-lasting immune responses in healthy adults in the U.S. and Liberia

In The News

IAVI’s Lassa fever vaccine shows promise in early clinical trials

CEPI News

November 5, 2025

In The News

Government drops support for key player in HIV vaccine development

Information, DK

November 3, 2025

Features

IAVI calls for innovative partnerships to sustain vaccine development at the World Vaccine Congress Europe 2025

October 30, 2025

IAVI’s experts underscored the value of equitable, regional partnerships in bringing new vaccines to market at this year’s convening in Amsterdam

IAVI Report

Dedication, not defeat

October 23, 2025

Drastic cuts to U.S. government funding imperil HIV/AIDS treatment and prevention programs and threaten HIV vaccine and cure research efforts across Africa. But the overarching view from East African researchers is one of resilience, not defeat.

IAVI Report

‘Of all the moments for science to slow down, this is not it.’

October 23, 2025

An HIV vaccine academy showcases the scientific talent of African researchers but is tempered by funding worries

Scientific Publications

Evidence required to evaluate the use of bacteriologically confirmed asymptomatic tuberculosis disease as a primary endpoint in prevention of tuberculosis disease vaccine licensure trials

1 234 5…246 of 246

Media & Resources

Filter by

Type

Health area

Location

Topic

Year

Journal

Publication

Fact sheet & publication type

Lassa vaccine candidate provides encouraging results in phase 1 trial

Encouraging results from a first-in-human Phase 1 clinical trial of IAVI’s Lassa vaccine candidate published in New England Journal of Medicine

IAVI’s Lassa fever vaccine shows promise in early clinical trials

Government drops support for key player in HIV vaccine development

IAVI calls for innovative partnerships to sustain vaccine development at the World Vaccine Congress Europe 2025

Dedication, not defeat

‘Of all the moments for science to slow down, this is not it.’

Evidence required to evaluate the use of bacteriologically confirmed asymptomatic tuberculosis disease as a primary endpoint in prevention of tuberculosis disease vaccine licensure trials

Subscription Type